Ocuphire Pharma Investor Day Presentation Deck slide image

Ocuphire Pharma Investor Day Presentation Deck

P VEGA-1: Functional Vision Durability Single Drop of Nyxol has Durable Response for 18 Hours 18 hours post Nyxol consistent efficacy with 12 hours 94 0.75% Nyxol Subjects achieving 3-line gain in photopic, binocular DCNVA (N=30) Time Point (Hrs post Nyxol dose) 12.5 18 Nyxol as a Single Drop 18 % of Subjects 33% 37% Subjects achieving 20/40 or better in photopic, N/A binocular DCNVA (N= 30) (compared to baseline) *Trend toward statistical significance even in smaller Nyxol arm from time 0 to time 6 hrs (n=30); larger sample size for all arms planned in Phase 3 program Statistics vs Placebo 60% p=0.07* p=0.11* VEGA-1 TLR Table 14.2.1.2 Percent of Subjects with Photopic DCNVA by Time Point (PP Population) and Table 14.2.24.1 Percent of Subjects with Photopic DCNVA by Time Point (PP Population) Ocuphire PHARMA
View entire presentation